News
News list
-
Registration Open for Preclinical Drug Development Course
Registration is now open for the first ZH3D Academy course series on Preclinical Drug Development. The three-part course provides practical and regulatory insights into nonclinical drug development and first-in-human enabling studies. Registration deadline: 7 October 2026.
-
University Medicine Zurich (UMZH) supports the expansion of regulatory expertise in the field of innovative medicines at ZH3D
On August 26, 2025, the UMZH Coordination Committee approved the application to fund a specialist in the regulatory field of Good Manufacturing Practice (GMP) for innovative medicines at ZH3D.
-
University of Zurich supports development of Zurich Hub for Drug and Medical Device Development (ZH3D)
On July 8, 2025, the Executive Board oft he University of Zurich decided to provide financial support for ZH3D as a technology and development platform.
-
New Zurich Hub for Drug & Device Development (ZH3D) Launched at UZH
Zurich, June 1, 2025 – A brand-new innovation platform, ZH3D, was officially founded at the University of Zurich (UZH) on June 1, led by Prof. Michael Hottiger and Prof. Thorsten Buch as Co-Directors, and Dr . Ralph Schiess as its inaugural CEO.